Cross border reproductive care in North America A pilot study testing a prospective data collection program for IVF clinics in Canada and the United States
Nonidentifying summary data on cross-border reproductive care were considered important by responding Canadian Fertility and Andrology Society and Society for Assisted Reproductive Technology members. However, only one center from these societies was willing to collect and submit data.
Edward G. Hughes, M.B., Ch.B., Angie Sawyer, M.Sc., Deirdre DeJean, Ph.D., G. David Adamson, M.D.
Volume 105, Issue 3, Pages 786-790
To develop and test a nonidentifying prospective data collection system for cross-border reproductive care (CBRC) in Canada and the United States (U.S.).
Survey and cross-sectional study.
Women traveling to and from Canada and the U.S. for reproductive care.
Main Outcome Measure(s):
Patients’ home country, reason for crossing borders, and type of care received.
Of 32 Canadian and 440 U.S. clinics contacted, seven and 46, respectively, responded to the initial questionnaire. Three out of seven Canadian and 44 out of 46 U.S. clinics reported providing CBRC. Seventy five percent agreed that nonidentifying data on country of origin and reason for travel should be collected. However, only one of seven Canadian and none of 46 U.S. clinics that expressed initial interest actually collected data, despite multiple communications.
Although CBRC is a major component of assisted reproductive technology in North America (3%–10% of IVF cycles are provided to out-of-country patients in Canada and the U.S.), clinicians are not motivated to collect the simplest of data regarding CBRC patients. Despite this, reliable data are needed to help better understand the reasons for and impact of CBRC.